Anticardiolipin Antibodies in COVID-19 – Report of Three Cases Cover

.blurhash-client-img { display: none !important; }

Anticardiolipin Antibodies in COVID-19 – Report of Three Cases

Internal Medicine

Volume 18 (2021): Issue 1 (January 2021)

By: Alina Dima, Ruxandra Valentina Moroti, Daniela Nicoleta Popescu, Ioana Berza, Delia Adriana Pârvu and Bianca Dumitrescu

Open Access

|Mar 2021

Authors

Alina Dima

Colentina Clinical Hospital, Bucharest, Romania

Ruxandra Valentina Moroti

ruxandra_moroti@yahoo.com

“Matei Balș” INBI, Bucharest, Romania

“Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania

Daniela Nicoleta Popescu

Colentina Clinical Hospital, Bucharest, Romania

Ioana Berza

Colentina Clinical Hospital, Bucharest, Romania

Delia Adriana Pârvu

Affidea Hiperdia Colentina Clinical Hospital, Bucharest, Romania

Bianca Dumitrescu

Colentina Clinical Hospital, Bucharest, Romania

DOI: https://doi.org/10.2478/inmed-2021-0151 | Journal eISSN: 1220-5818 | Journal ISSN: 1220-5818

Journal RSS Feed

Language: English

Page range: 59 - 67

Published on: Mar 13, 2021

Published by: Romanian Society of Internal Medicine

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

antiphospholipid syndrome,

lupus coagulant inhibitor,

Related subjects:

Clinical medicine,

Internal medicine,

Internal medicine, other,

Gastroenterology,

© 2021 Alina Dima, Ruxandra Valentina Moroti, Daniela Nicoleta Popescu, Ioana Berza, Delia Adriana Pârvu, Bianca Dumitrescu, published by Romanian Society of Internal Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 18 (2021): Issue 1 (January 2021)Next article